LOPINAVIR
Substance profile for UNII 2494G1JF75, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.
Structure render from PubChem CID 92727Substance Identity#
- UNII
- 2494G1JF75
- Preferred term
- LOPINAVIR
- Registry number
- 192725-17-0
- Ingredient type
- INGREDIENT SUBSTANCE
- Molecular formula
- C37H48N4O5
Chemical And Database Identifiers#
- InChIKey
- KJHKTHWMRKYKJE-SUGCFTRWSA-N
- SMILES
- CC(C)[C@H](N1CCCNC1=O)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)COC3=C(C)C=CC=C3C)CC4=CC=CC=C4
- RxCUI
- 195088
- PubChem
- 92727
- NCIt
- C2095
- INN ID
- 7798
DailyMed Socrata Ingredients#
Type, DailyMed label, SPL version table| Type | DailyMed label | SPL version |
|---|
| ACTIVE INGREDIENT | These highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir/ritonavir) Tablet, Film Coated for Oral use KALETRA (lopinavir/ritonavir) Solution for Oral use Initial U.S. Approval: 2000 | 1 |
| ACTIVE MOIETY | These highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir/ritonavir) Tablet, Film Coated for Oral use KALETRA (lopinavir/ritonavir) Solution for Oral use Initial U.S. Approval: 2000 | 1 |
| ACTIVE MOIETY | These highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir/ritonavir) Tablet, Film Coated for Oral use KALETRA (lopinavir/ritonavir) Solution for Oral use Initial U.S. Approval: 2000 | 1 |
| ACTIVE INGREDIENT | These highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir/ritonavir) Tablet, Film Coated for Oral use KALETRA (lopinavir/ritonavir) Solution for Oral use Initial U.S. Approval: 2000 | 1 |
| ACTIVE MOIETY | These highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir and ritonavir) Tablet, Film Coated for Oral use KALETRA (lopinavir and ritonavir) Solution for Oral use Initial U.S. Approval: 2000 | 2 |
| ACTIVE INGREDIENT | These highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir and ritonavir) Tablet, Film Coated for Oral use KALETRA (lopinavir and ritonavir) Solution for Oral use Initial U.S. Approval: 2000 | 2 |
| ACTIVE MOIETY | These highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir and ritonavir) Tablet, Film Coated for Oral use KALETRA (lopinavir and ritonavir) Solution for Oral use Initial U.S. Approval: 2000 | 1 |
| ACTIVE INGREDIENT | These highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir and ritonavir) Tablet, Film Coated for Oral use KALETRA (lopinavir and ritonavir) Solution for Oral use Initial U.S. Approval: 2000 | 1 |
| ACTIVE MOIETY | These highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir and ritonavir) Tablet, Film Coated for Oral use KALETRA (lopinavir and ritonavir) Solution for Oral use Initial U.S. Approval: 2000 | 1 |
| ACTIVE INGREDIENT | These highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir and ritonavir) Tablet, Film Coated for Oral use KALETRA (lopinavir and ritonavir) Solution for Oral use Initial U.S. Approval: 2000 | 1 |
| ACTIVE INGREDIENT | KALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED KALETRA (LOPINAVIR AND RITONAVIR) SOLUTION [ABBVIE INC.] | 1567 |
| ACTIVE MOIETY | KALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED KALETRA (LOPINAVIR AND RITONAVIR) SOLUTION [ABBVIE INC.] | 1567 |
| ACTIVE INGREDIENT | KALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.] | 1405 |
| ACTIVE MOIETY | KALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.] | 1405 |
| ACTIVE INGREDIENT | KALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED [CARDINAL HEALTH] | 4 |
| ACTIVE MOIETY | KALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED [CARDINAL HEALTH] | 4 |
| ACTIVE INGREDIENT | KALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY] | 1 |
| ACTIVE MOIETY | KALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY] | 1 |
pubchem.ncbi.nlm.nih.gov/compound/92727
mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=195088
ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2095
precision.fda.gov/uniisearch/srs/unii/2494G1JF75